5 pharmaceutical preparation, namely, a recombinant, human monoclonal antibody antigen-binding fragment designed to reverse the antiplatelet activity of ticagrelor in major bleeding and urgent surgery situations.
The mark consists of two parallel arrow shapes pointing left adjacent to a larger right-facing arrow shape. Color is not claimed as a feature of the mark.
Trademark: 98431531
